Cited by 33Cervical Cancer and HPV ResearchReproductive tract infections researchGenital Health and Disease

Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.

Open access
Nah, Eun-Hee, Cho, Seon, Kim, Suyoung, Cho, Han-Ik·2017·Annals of Laboratory Medicine

Abstract

BACKGROUND: The prevalence and genotype distribution of Human papillomavirus (HPV) infection vary depending on geographical region and the immunity provided by vaccines. This study aimed to clarify the recent prevalence and genotype distribution of HPV according to age and cervical cytology findings in Korea. METHODS: This study included 18,815 health examinees that underwent cervical cytology and HPV genotyping tests at 16 centers of Korean Association of Health Promotion in 13 cities in Korea, between January 2014 and October 2015. HPV was genotyped by using multiplex PCR (Anyplex II HPV 28, Seegene, Korea), which detects 19 high-risk HPVs (HR-HPV) and nine low-risk HPVs (LR-HPV). RESULTS: Overall HPV prevalence was 27.8%, with 22.2% HR-HPV and 11.4% LR-HPV. The five most common carcinogens were HPV 52 (3.2%), 58 (2.7%), 16 (2.0%), 56 (1.9%), and 51 (1.8%). The five most common HR-HPVs in normal cytology samples were HPV 53, 68, 70, 52, and 58, while HPV 16, 52, 58, 33, and 31 were prevalent in high grade squamous intraepithelial lesions (HSIL). In atypical squamous cells of undetermined significance (ASCUS), the prevalence of HR-HPV varied with age; it was highest in those aged <30 yr, declining to a minimum at age 50-59 yr, and then increasing in older women (P<0.05). CONCLUSIONS: The prevalence and distribution of HR-HPV varied with age and cervical cytology findings. This information would be helpful in the development of cervical cancer prevention policies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3343/alm.2017.37.5.426

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [1]Torre LA Bray F Siegel RL Ferlay J Lortet-Tieulent J Jemal A Global cancer statistics, 2012 CA Cancer J Clin 2015 65 87 108 25651787
  2. [3]Meijer CJ Snijders PJ Castle PE Clinical utility of HPV genotyping Gynecol Oncol 2006 103 12 17 16934860
  3. [4]Saslow D Solomon D Lawson HW Killackey M Kulasingam SL Cain J American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Am J Clin Pathol 2012 137 516 542 22431528
  4. [5]Bernard HU Burk RD Chen Z van Doorslaer K zur Hausen H de Villiers EM Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments Virology 2010 401 70 79 20206957 PMC3400342
  5. [6]de Sanjosé S Diaz M Castellsagué X Clifford G Bruni L Muñoz N Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Lancet Infect Dis 2007 7 453 459 17597569
  6. [7]Bae JH Lee SJ Kim CJ Hur SY Park YG Lee WC Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis J Microbiol Biotechnol 2008 18 788 794 18467878
  7. [8]Kim MJ Kim JJ Kim S Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women Obstet Gynecol Sci 2013 56 110 120 24327989 PMC3784093
  8. [9]Shin HR Lee DH Herrero R Smith JS Vaccarella S Hong SH Prevalence of human papillomavirus infection in women in Busan, South Korea Int J Cancer 2003 103 413 421 12471626
  9. [10]Solomon D Davey D Kurman R Moriarty A O'Connor D Prey M The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 2002 287 2114 2119 11966386
  10. [11]Schiffman M Clifford G Buonaguro FM Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Infect Agent Cancer 2009 4 8 19486508 PMC2694995
  11. [12]IARC Agents classified by the IARC monographs, vol. 1-118 Updated on May 2017 http://monographs.iarc.fr/ENG/Classification/index.php
  12. [13]Kim JK Jeon JS Lee CH Kim JW Prevalence and genotype distribution of human papillomavirus in Cheonan, Korea J Microbiol Biotechnol 2014 24 1143 1147 24861343
  13. [14]Lee EH Um TH Chi HS Hong YJ Cha YJ Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay J Korean Med Sci 2012 27 1091 1097 22969258 PMC3429829
  14. [15]Rhee JE Shin MY Kim CM Kee HY Chung JK Min SK Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development Virol J 2010 7 201 20738861 PMC2936902
  15. [16]Mesher D Panwar K Thomas SL Beddows S Soldan K Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study BMJ Open 2016 6 e009915 PMC4762111 26868944
  16. [17]Markowitz LE Hariri S Lin C Dunne EF Steinau M McQuillan G Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010 J Infect Dis 2013 208 385 393 23785124
  17. [18]Tabrizi SN Brotherton JM Kaldor JM Skinner SR Cummins E Liu B Fall in human papillomavirus prevalence following a national vaccination program J Infect Dis 2012 206 1645 1651 23087430
  18. [19]Heard I Tondeur L Arowas L Falguières M Demazoin MC Favre M Human papillomavirus types distribution in organised cervical cancer screening in France PLoS One 2013 8 e79372 24244490 PMC3828354
  19. [20]Howell-Jones R Bailey A Beddows S Sargent A de Silva N Wilson G Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England Br J Cancer 2010 103 209 216 20628396 PMC2906740
  20. [21]Bosch FX Burchell AN Schiffman M Giuliano AR de Sanjose S Bruni L Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia Vaccine 2008 26 S10 K1 K16 18847553
  21. [22]Malagón T Drolet M Boily MC Franco EL Jit M Brisson J Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis Lancet Infect Dis 2012 12 781 789 22920953
  22. [23]Wheeler CM Castellsagué X Garland SM Szarewski A Paavonen J Naud P Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 2012 13 100 110 22075170
  23. [24]Franceschi S Herrero R Clifford GM Snijders PJ Arslan A Anh PT Variations in the age-specific curves of human papillomavirus prevalence in women worldwide Int J Cancer 2006 119 2677 2684 16991121
  24. [25]Gravitt PE Rositch AF Silver MI Marks MA Chang K Burke AE A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States J Infect Dis 2013 207 272 280 23242540 PMC3532829
  25. [26]Althoff KN Paul P Burke AE Viscidi R Sangaramoorthy M Gravitt PE Correlates of cervicovaginal human papillomavirus detection in perimenopausal women J Womens Health (Larchmt) 2009 18 1341 1346 19702476 PMC2825723
  26. [27]Muñoz N Méndez F Posso H Molano M van den Brule AJ Ronderos M Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results J Infect Dis 2004 190 2077 2087 15551205

Cited by

Sorted by citations

Authors
Nah, E.-H., Cho, S., Kim, S., & Cho, H.-I.
Affiliations
Korea Association of Health Promotion (KR)
Corresponding author
Nah, Eun-Hee
Venue
Annals of Laboratory Medicine
Published
2017-09-01
Volume
37
Issue
5
Pages
426-433
ISSN
  • 2234-3806 (ISSN-L)
  • 2234-3814
OpenAlex
W2731431462
Cited by
33
References
1
Citations by year
2026: 4 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 5
FWCI
1.93
Type
journal article
Language
en
Open access
Locations
  • Annals of Laboratory Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Korean Association of Health Promotion
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Surgery › Genital Health and Disease
Keywords
human papillomavirus, HPV genotype distribution, HPV prevalence, high-risk HPV, low-risk HPV, cervical cytology, ASCUS, high-grade squamous intraepithelial lesion, HPV16, HPV52, HPV58, Korean women
MeSH terms
Adult, Aged, Cervix Uteri, Cities, Cross-Sectional Studies, DNA, Viral, Female, Genotype, Humans, Middle Aged, Retrospective Studies, Prevalence, Papillomaviridae, Papillomavirus Infections, Young Adult, Republic of Korea, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review